Research location
Harleysville
Pennsylvania, United States
Advertisement
Research activity in Harleysville
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 34 trials and 35 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Harleysville
34 linked trials · page 1 of 1Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic TrialNCT03596450 · 2018-07-13 · 1 site observation
COMPLETED
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminNCT03060980 · 2017-03-03 · 1 site observation
TERMINATED
Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesNCT02730377 · 2016-03-28 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.NCT02648204 · 2016-01-06 · 1 site observation
COMPLETED
Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes MellitusNCT02465515 · 2015-07-01 · 1 site observation
COMPLETED
A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusNCT01991795 · 2014-02-10 · 1 site observation
COMPLETED
Fasiglifam 25 mg BID vs 50 mg QDNCT01982253 · 2013-10-01 · 1 site observation
TERMINATED
TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesNCT01829464 · 2013-05-01 · 1 site observation
TERMINATED
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 DiabetesNCT01652716 · 2013-01-01 · 1 site observation
COMPLETED
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesNCT01715818 · 2012-12-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesNCT01456195 · 2011-11-01 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)NCT01106625 · 2010-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneNCT01089790 · 2010-03-01 · 1 site observation
TERMINATED
Nebivolol in Patients With Systolic Stage 2 HypertensionNCT01057251 · 2010-03-01 · 1 site observation
COMPLETED
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneNCT00970424 · 2009-08-01 · 1 site observation
TERMINATED
Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive PatientsNCT00734630 · 2008-08-01 · 1 site observation
COMPLETED
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting GlucoseNCT00673790 · 2008-05-15 · 1 site observation
COMPLETED
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 DiabeticsNCT00698230 · 2008-05-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01 · 1 site observation
COMPLETED
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes MellitusNCT00519142 · 2007-08-01 · 1 site observation
COMPLETED
Airway Limitation Study: Study In Primary Care Centers Of Chronic Bronchitis In Long-Term Cigarette Smokers Of At Least 40 Years Of Age With Symptoms Of Cough And Shortness Of BreathNCT00442468 · 2007-04-01 · 1 site observation
COMPLETED
Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusNCT00395512 · 2006-11-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 2 site observations
COMPLETED
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionNCT00281593 · 2006-04-01 · 1 site observation
COMPLETED
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneNCT00295633 · 2006-03-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral NeuropathyNCT00283842 · 2006-03-01 · 1 site observation
TERMINATED
Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 HypertensionNCT00168779 · 2005-09-01 · 1 site observation
COMPLETED
Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight LossNCT00471172 · 2004-08-01 · 1 site observation
COMPLETED
PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)NCT00274638 · 2002-07-01 · 1 site observation
COMPLETED
Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed DoseNCT00034840 · 2001-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.